Collegium Pharmaceutical Inc (COLL)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 483,838 527,709 571,419 614,991 538,451 581,902 625,268 668,579 201,632 213,570 225,455 237,292 209,594 219,762 229,908 240,094 7,667 8,625 9,583 9,036
Total stockholders’ equity US$ in thousands 195,431 178,873 200,805 179,733 194,842 197,194 197,612 196,076 202,928 251,094 253,066 170,035 186,031 172,686 155,767 141,063 87,432 84,258 85,823 86,350
Debt-to-capital ratio 0.71 0.75 0.74 0.77 0.73 0.75 0.76 0.77 0.50 0.46 0.47 0.58 0.53 0.56 0.60 0.63 0.08 0.09 0.10 0.09

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $483,838K ÷ ($483,838K + $195,431K)
= 0.71

Collegium Pharmaceutical Inc's debt-to-capital ratio has shown some fluctuations over the past eight quarters. The ratio ranged from a low of 0.77 in Q4 2023 to a high of 0.82 in Q1 2023. Generally, the company's debt-to-capital ratio has been relatively stable, hovering around the range of 0.77 to 0.82. This indicates that Collegium Pharmaceutical maintains a significant portion of its capital structure in the form of debt. It is important to continue monitoring this ratio to ensure that the company's leverage level remains within acceptable limits and does not pose significant risks to its financial stability.